LFCR NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Lifecore Biomedical Inc. · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 5.01 USD
13.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -11.2% below the Trend Line and sits at 25.9% of its 52-week range. The latest completed week returned 13.3%, after a 5.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 60/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.

Setup score 30 out of 100
Latest Close 5.01 USD 7 Aug 2026
1W Return 13.3% latest completed week
4W Return 5.5% short-term follow-through
12W Return 13.9% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 13.3% Latest completed week; four-week move 5.5%. Indicator stack 21/36 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 60/100 conviction; expected move 17.0%. News sentiment 55/100 40 relevant articles in the latest sentiment read. Event risk 05 Aug Latest stored earnings date was 05 Aug 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -11.2% below the Trend Line and sits at 25.9% of its 52-week range. The latest completed week returned 13.3%, after a 5.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1212-week average 0.11

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.5% over four weeks, 13.9% over 12 weeks, and -30.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W13.3%
4W5.5%
12W13.9%
26W-33.8%
52W-30.8%
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.18Latest activity-pressure read.
Pressure change-137.3%Four-week change in activity pressure.
Leadership-32.38Latest relative-leadership reading.
RS change17.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 May 2026 Field coverage 85% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength54/100Blend of value, momentum, and quality. Underlying universe rank 47; rank 1 is best.
Value52/100Relative valuation strength. Underlying universe rank 49; rank 1 is best.
Quality49/100Profitability and accounting quality. Underlying universe rank 52; rank 1 is best.
Momentum51/100Medium-term price momentum. Underlying universe rank 50; rank 1 is best.
Growth52/100Revenue and earnings growth. Underlying universe rank 49; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
39.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
31.4%
Gross profit retained from each unit of revenue.
Operating margin
-1.0%
Operating profit retained from revenue.
Free-cash-flow margin
14.6%
Free cash flow generated from revenue.
Return on invested capital
-0.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
16.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

LFCR shows volatility options pressure with a 60/100 conviction score, put-call volume ratio of 7.06, expected move of 17.0%, and Sharemaestro trend signal inactive.

Conviction60/100
Expected move17.0%
Put/call volume7.06
Pressure-68
Speculation18
Volatility96
Trend agreement69
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 40 relevant articles.

13 positive · 24 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings05 AugLatest stored earnings date was 05 Aug 2026.
Options expected move17.0%Nearest-chain priced movement where available.
52-week drawdown-44.2%Distance below the 52-week high.
13-week volatility7.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+23.7%Week of 10 Apr.
Worst week-38.5%Week of 20 Mar.
Latest week+13.3%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains5
Flat weeks0
Modest losses4
Sharp losses10
Recent vol7.3%13-week weekly-return volatility.
Base vol9.0%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis21/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.12; No reversal markers Factors51/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 49; Small Cap Core rank 53 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options58/100

LFCR shows volatility options pressure with a 60/100 conviction score, put-call volume ratio of 7.06, expected move of 17.0%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 17.0% Sentiment55/100

Weighted news tone is neutral across 40 relevant articles.

Lifecore Biomedical Inc (LFCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders50/100

No recent insider transaction evidence is stored.

 Earnings05 Aug

Latest stored earnings date was 05 Aug 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20265.01 USD13.3%5.64 USD6.51 USD-0.18-32.38811.7KOff
31 Jul 20264.42 USD2.1%5.73 USD6.54 USD-0.16-37.97775.7KOff
24 Jul 20264.33 USD-7.5%5.84 USD6.58 USD0.06-39.60593.5KOff
17 Jul 20264.68 USD-1.5%5.97 USD6.62 USD0.39-36.56752.7KOff
10 Jul 20264.75 USD-6.7%6.08 USD6.66 USD0.49-39.03810.9KOff
3 Jul 20265.09 USD-1.5%6.18 USD6.69 USD0.50-34.471.2MOff
26 Jun 20265.17 USD-6.7%6.27 USD6.72 USD0.41-33.731.8MOff
19 Jun 20265.54 USD-1.8%6.36 USD6.75 USD0.14-33.08730.0KOff
12 Jun 20265.64 USD0.2%6.43 USD6.77 USD-0.03-30.73702.2KOff
5 Jun 20265.63 USD12.2%6.51 USD6.79 USD-0.31-29.861.3MOff
29 May 20265.02 USD1.8%6.55 USD6.80 USD-0.60-40.77681.4KOff
22 May 20264.93 USD12.0%6.62 USD6.82 USD-0.75-40.78995.5KOff
15 May 20264.40 USD-8.1%6.68 USD6.84 USD-0.88-47.061.0MOff
8 May 20264.79 USD-8.9%6.75 USD6.85 USD-0.86-43.21934.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context